Drugs / Travesol 10%
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07030933 | Oct 2026 → Oct 2027 expected | acute kidney injury | Milton S. Hershey Medical Center | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Travesol 10% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07030933 ↗ |